Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis

BACKGROUND: Non-alcoholic fatty liver disease is a prohaemostatic state with abnormal primary, secondary and tertiary haemostasis. Plasminogen activator inhibitor (PAI)-1 is the best-established marker for prohaemostasis in non-alcoholic fatty liver disease. While epidemiological studies demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivas, Gloriany, Hummer-Bair, Breianna, Bezinover, Dmitri, Kadry, Zakiyah, Stine, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330585/
https://www.ncbi.nlm.nih.gov/pubmed/34341018
http://dx.doi.org/10.1136/bmjgast-2021-000683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330585/
https://www.ncbi.nlm.nih.gov/pubmed/34341018
http://dx.doi.org/10.1136/bmjgast-2021-000683

Ejemplares similares